RABI HANNA

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology CLEVELAND, OH NPI 1497958243

General Payments — all program years on this page

$109,271.17

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 137
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $24,010.08 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
VERTEX PHARMACEUTICALS INCORPORATED $11,044.658
CHIESI USA, INC. $7,640.164
SOBI, INC $5,325.275

By program year

Program yearAmountRecords
2018 $5,973.519
2019 $31,522.5244
2020 $6,064.878
2021 $1,000.001
2022 $22,347.6724
2023 $18,352.5234
2024 $24,010.0817

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105904250 VERTEX PHARMACEUTICALS INCORPORATED $16.43 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105907695 VERTEX PHARMACEUTICALS INCORPORATED $33.83 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105910504 VERTEX PHARMACEUTICALS INCORPORATED $687.08 11/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105911878 VERTEX PHARMACEUTICALS INCORPORATED $26.29 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105914620 VERTEX PHARMACEUTICALS INCORPORATED $4.95 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105916682 VERTEX PHARMACEUTICALS INCORPORATED $158.46 11/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105918058 VERTEX PHARMACEUTICALS INCORPORATED $37.61 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105920137 VERTEX PHARMACEUTICALS INCORPORATED $10,080.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141409108 SOBI, INC $3,300.00 10/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1141409110 SOBI, INC $124.08 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141409180 SOBI, INC $349.37 10/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141409198 SOBI, INC $231.82 10/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141417888 SOBI, INC $1,320.00 03/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1151808046 Chiesi USA, Inc. $572.22 06/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1151808050 Chiesi USA, Inc. $61.94 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151808055 Chiesi USA, Inc. $46.00 08/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1151808059 Chiesi USA, Inc. $6,960.00 08/22/2024 Honoraria Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.